Stanford scientists have developed an accurate, rapid, and efficient tool for in vivo microglial manipulation to validate gene functions after transcriptomic analysis.
Researchers in Prof. Monte Winslow's laboratory have developed two viable, fertile transgenic mouse strains that enable rapid, simple generation of loss-of-function models with CRISPR/Cas9 mediated genome editing in vivo or ex vivo.